1. World Health Organization. International Agency for Research on
Cancer. Latest Global Cancer Data 2020. Available from: https://
www.iarc.who.int.
2. Kreidieh FY, Moukadem HA, Saghir NS. Overview, prevention
and management of chemotherapy extravasation. World J Clin
Oncol 2016;7:87‑97.
3. Amjad MT, Chidharla A, Kasi A. Cancer Chemotherapy.
StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing;
2022 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/
NBK564367/.
4. PengQ, WuW. Development and validation of oral chemotherapy
self‑management scale. BMC Cancer 2020. doi: 10.1186/
s12885‑020‑07404‑0.
5. Grunigen SV, Geissbuhlar A, Bonnabry P. Cyto‑SAT:
A self‑assessment tool for the safe handling of cytotoxic drugs
adapted for use in low‑ and middle‑income countries. J Oncol
Pharm Pract 2021;27:1422‑31.
6. Tofthagen CS, McMillan SC, Kip KE. Development and
psychometric evaluation of the chemotherapy‑induced
peripheral neuropathy assessment tool. Cancer Nurs
2011;34:E10‑20.
7. Kim SH, Park JH. Develop and validate nutrition screening tool for
hospitalized cancer patients. J Korean Acad Nurs 2012;42:632‑43.
8. Kano T, Kanda K. Development and validation of a
chemotherapy‑induced taste alteration scale. Oncol Nurs Forum
2013;40:E79‑85.
9. Jeyaram S, Veeraiah S, Elangovan V. Validation of the symbolic
assessment of fatigue extent (SAFE)‑a cancer fatigue tool with
visual response formats. Support Care Cancer 2017;25:1111‑9.
10. Maguire R, Kotronoulas G, Donnan PT, Paterson C, McCann L,
Connaghan J, et al. Development and preliminary testing of a brief
clinical tool to enable daily monitoring of chemotherapy toxicity:
The daily chemotherapy toxicity self‑ assessment questionnaire.
Eur J Cancer Care 2018;27:e12890.
11. Kanda K, Fujimoto K, Mochizuki R, Ishida K, Lee B. Development
and validation of the comprehensive assessment scale for
chemotherapy‑induced peripheral neuropathy in survivors of
cancer. BMC Cancer 2019;19:904.